About John Rabb

John Rabb

John Rabb attended California State University, Fresno, where he received a Bachelor of Arts degree in English Nonfiction Prose Writing in 2001 and a Master of Fine Arts (MFA) degree in Creative Nonfiction Writing in 2007. He was the first annual recipient of the Lillian Faderman Creative Nonfiction Scholarship, and won the Association of Writers & Writing Programs (AWP) Intro to Journals Award in 2003. His work has been published in various literary journals and print publications. He is also a lifetime member of the Phi Kappa Phi collegiate academic honor society.

Articles Submitted by John Rabb:
  • NuvaRing Blood Clot Lawsuits on the Rise
  • Actos Bladder Cancer Lawsuits Consolidated in California
  • Topamax Oral Cleft Defect Risk May Hinder Approval of New Diet Drug
  • Transvaginal Mesh Sales Drop in 2011
  • FDA Calls for New Restrictions on Multaq Use
  • Health Canada: Bisphosphonates Double Risk for Atypical Bone Fractures
  • Federal Panel Rejects Plavix MDL Consolidation
  • Motion Filed to Consolidate Wright Conserve Hip Lawsuits
  • PPI Bone Fracture Lawsuit Filed in California
  • Chantix Litigation Moving Forward
  • FDA Denies Public Citizen’s Plea to Recall Avandia
  • Accutane IBD Lawsuit Filed by New Jersey Woman
  • Darvon & Darvocet MDL Claims Continue to Grow Nationwide
  • Avastin Breast Cancer Approval Revoked by FDA
  • Federal Judge: Protected Yaz Discovery Files Cannot be Shared with FDA
  • Ethicon/Gynecare Transvaginal Mesh Bellwether Trials Set for November 2012
  • GSK Urged to Resolve Avandia Lawsuit Settlement Negotiations
  • Actos Bladder Cancer Risk Cuts Into Takeda’s Bottom Line
  • FTC Settles Hoodia Deceptive Advertising Claims
  • Chantix ‘Black Box’ Warning Not Severe Enough, Study Says
  • FDA Panel Recommends Vytorin for Treatment of Chronic Kidney Disease (CKD)
  • JAMA: Alcohol Consumption Linked to Breast Cancer in Women
  • Can Glucocorticoid Steroids Cause Brain Damage in Premature Babies?
  • Newer Birth Control Pills Increase Blood Clot Risk
  • Are Multivitamins and Dietary Supplements Worthless?
  • Brown Signs Hotly-Debated STD Vaccine Bill Into Law
  • Pennsylvania Man Awarded Nearly $50M in Motrin Side Effects Lawsuit
  • Merck Wins Fourth Fosamax Bellwether Trial